Evaluating the clinical effectiveness of repeat screening for gestational diabetes mellitus following a diagnosis of large for gestational age and/or polyhydramnios
Bewertung der klinischen Wirksamkeit einer Wiederholungs-Screening auf Gestationsdiabetes nach Diagnose eines großen Gestationsalters und/oder Polyhydramnion
Pregnancy · 2026-01 · 2 (1)
DOI: 10.1002/pmf2.70209 ↗Auf einen Blick
In einer retrospektiven Kohortenstudie hatten Schwangere mit LGA und/oder Polyhydramnion ohne erneutes GDM-Screening keine schlechteren Geburtsoutcomes als erneut Gescreente. Bei erneut Gescreenten traten 13,8 % GDM-Diagnosen auf.
Fragestellung
Sind die Outcomes bei Schwangeren mit LGA und/oder Polyhydramnion anders, wenn nach normalem GDM-Screening erneut gescreent wird oder nicht?
Methode
Retrospektive Kohortenstudie von Januar 2011 bis März 2024 bei Terminschwangerschaften mit Einlingsgeburt nach normalem GDM-Screening in Woche 24–30; Vergleich von Nicht-Rescreening und Rescreening mittels Mixed Model und logistischer Regression.
Ergebnisse
1665 Schwangere: 1317 ohne Rescreening, 348 mit Rescreening. Bei Rescreening 13,8 % GDM, davon 20,8 % medikamentös behandelt. Keine schlechteren Outcomes ohne Rescreening; neonataler Hypoglykämie-Risikoanstieg nur bei GDM nach Rescreening (7,0 % vs. 22,9 %; OR 3,95, 95 %-KI 1,76–8,84).
Schlussfolgerung der Autor:innen
Die Autor:innen schließen, dass ein erneutes GDM-Screening bei allen Personen mit LGA und/oder Polyhydramnion möglicherweise nicht gerechtfertigt ist.
Kernaussagen
- Ohne Rescreening keine schlechteren Geburtsoutcomes
- 13,8 % der Rescreening-Gruppe erhielten eine GDM-Diagnose
- Neonatale Hypoglykämie häufiger bei GDM nach Rescreening
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Pregnancy, online erschienen am 07.01.2026. Verfasst von H Tal Lesser und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology Geisinger Danville Pennsylvania USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
Gestational diabetes mellitus (GDM) screening is often repeated in the third trimester when large for gestational age (LGA) and/or polyhydramnios are diagnosed. We evaluated outcomes for individuals who did versus did not rescreen, and also for individuals who passed or did not pass rescreening.
Methods
A retrospective cohort study from January 2011 to March 2024 of term, singleton pregnancies diagnosed with LGA and/or polyhydramnios after a normal GDM screen at 24–30 weeks was performed. Non‐inferiority analyses were performed for the comparison between those who did not rescreen and those who did rescreen (passed or did not pass) using a mixed model. In non‐inferiority analyses, if the lower bound of a one‐sided 95% confidence interval (CI) is within the non‐inferiority limit (margin of error), the test is significant, allowing non‐inferiority to be declared. The lower bound of the 95% CI and corresponding p values were reported. Outcomes in individuals who passed and who did not pass rescreening were compared using a logistic regression model. Odds ratios with respective 95% CI and p values are reported.
Results
Of the 1665 pregnant individuals who met the inclusion criteria, 1317 did not rescreen and 348 rescreened. In individuals who were rescreened, 13.8% were diagnosed with GDM, of which 20.8% required medication. Outcomes were not worse for those who did not rescreen than for those who did rescreen, including birthweight (BW) (3758 vs. 3813 g, −123.65, p < 0.01), BW ≥ 4000 (31.9% vs. 34.1%, −0.32, p < 0.01), cesarean delivery (21.0% vs. 28.0%, 3.15, p < 0.01), or shoulder dystocia (5.2% vs. 6.6%, −1.47, p < 0.01). Outcomes for individuals who did rescreen did not differ whether they passed or failed, aside from an increase in neonatal hypoglycemia (7.0% vs. 22.9%, 3.95 [95% CI, 1.76–8.84], p < 0.01).
Conclusion
Pregnant individuals who did not rescreen for GDM following the diagnosis of LGA and/or polyhydramnios in the third trimester do not appear to have worse birth outcomes than those who did rescreen. Additionally, individuals diagnosed with GDM after rescreening were not at an increased risk for adverse perinatal outcomes. This study demonstrates that rescreening all individuals with LGA and/or polyhydramnios may not be warranted.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology Geisinger Danville Pennsylvania USA.
- Biostatistics Core Department of Population Health Sciences Geisinger Danville Pennsylvania USA.
- Department of Population Health Sciences Phenomic Analytics & Clinical Data Core Geisinger Danville Pennsylvania USA.
ORCID-Profile: H Tal Lesser
Zitieren
APA
Lesser, H. T., Mackeen, A. D., Chromey, D., Young, A. J., Gray, C., & Paglia, M. J. (2026). Evaluating the clinical effectiveness of repeat screening for gestational diabetes mellitus following a diagnosis of large for gestational age and/or polyhydramnios. Pregnancy, 2(1). https://doi.org/10.1002/pmf2.70209
Vancouver
Lesser HT, Mackeen AD, Chromey D, Young AJ, Gray C, Paglia MJ. Evaluating the clinical effectiveness of repeat screening for gestational diabetes mellitus following a diagnosis of large for gestational age and/or polyhydramnios. Pregnancy. 2026;2(1). doi:10.1002/pmf2.70209
BibTeX
@article{Lesser2026,
author = {Lesser, H Tal and Mackeen, A D and Chromey, David and Young, Amanda J and Gray, Celia and Paglia, Michael J},
title = {Evaluating the clinical effectiveness of repeat screening for gestational diabetes mellitus following a diagnosis of large for gestational age and/or polyhydramnios},
journal = {Pregnancy},
year = {2026},
volume = {2},
number = {1},
doi = {10.1002/pmf2.70209}
}
EUVIMED